Lamivudine
- Product NDC
- 64330-001
- 11-digit product format
- 643300001
- Labeler code
- 64330
- Product ID
- 64330-001_3d12167b-8a38-4ebe-820a-a69e0a51d504
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Centaur Pharmaceuticals Private Limited
- Application
- ANDA203586
- Marketing category
- ANDA
- Marketing start
- 2017-06-22
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64330-001-01 | Lamivudine | 60 in 1 BOTTLE | TABLET | 60 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64330-001 | LAMIVUDINE TABLET [CENTAUR PHARMACEUTICALS PRIVATE LIMITED] | 4 | Legacy NDC, 1 package rows | 20170622_8a510b4f-4d44-432e-9c06-4ca14dabcb08.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 64330-001-01 | 64330000101 | 60 in 1 BOTTLE | Historical |